High Tech Pharm amends 2026 H1 report to add treasury share holdings disclosure
Corrected 2026 H1 report filed Sept. 29 adds omitted treasury share disclosures: 575 common shares, 0.0054% of shares outstanding as of June 30.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.